Agfa HealthCare’s IMPAX HeartStation enables quick diagnosis of 15-business lead ECG studies when compared to 12-lead ECG studies at Western Maryland Regional Medical Center Agfa HealthCare, a respected provider of diagnostic healthcare and imaging It all solutions, today announces that Western Maryland Regional Medical Center’s recent update to the newest version of IMPAX HeartStation ECG Management Program has helped enable the quick diagnosis and treatment of patients with posterior wall heart attacks online pharmacy prescription drugs . The Cumberland-based medical center is using the recently released top features of IMPAX HeartStation to digitally review and archive 15-lead ECG studies.
The initial panel offered this year, the UltraSEEK Oncogene Panel, uses 40 nanograms of input DNA to interrogate 26 driver mutations in 12 critical oncogenes. Tumors harbor many cells with differing genetic mutations. While some of these cells might contain mutations that confer resistance to targeted inhibitors, they could compose such a miniscule element of the tumor that these cells are not detected using regular genotyping and sequencing methodologies. Additionally, they restrict analysis to stable tumor force and samples compromise between sample amount and depth of protection. In the rare case low-level mutations were detected using newer methodologies such as for example digital PCR, few if any scholarly studies have addressed the utility of the low-level mutations in the context of therapeutic response.